These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28653629)

  • 1. How artificial is the antibiotic resistance definition?
    Diene SM; Abat C; Rolain JM; Raoult D
    Lancet Infect Dis; 2017 Jul; 17(7):690. PubMed ID: 28653629
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
    Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
    J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
    Murphy ME; Powell E; Courter J; Mortensen JE
    BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
    Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
    Ponte C; Parra A; Nieto E; Soriano F
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
    Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
    Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?
    Ortega M; Marco F; Soriano A; Gómez J; Almela M; Mensa J
    Int J Antimicrob Agents; 2004 Aug; 24(2):178-80. PubMed ID: 15288318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
    Decousser JW; Methlouthi I; Pina P; Allouch P;
    J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in drug resistance in pneumococcal community-acquired pneumonia.
    Obando I; Arroyo L; Sanchez-Tatay D
    Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic sensitivity of Streptococcus pneumoniae in Tunisia: results of a multicenter study (1998-1999)].
    Mahjoubi-Rhimi F; Kechrid A; Boutiba I; Mezghani S; Kamoun A; Smaoui H; Thabet L; Ben Redjeb S; Hammami A
    Tunis Med; 2003 Mar; 81(3):167-71. PubMed ID: 12793066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
    Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
    J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece.
    Kanavaki S; Mantadakis E; Karabela S; Anatoliotaki M; Makarona M; Moraitou H; Pefanis A; Samonis G
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):693-6. PubMed ID: 16261303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia.
    Soriano F; Ponte C; Nieto E; Parra A
    J Antimicrob Chemother; 1996 Aug; 38(2):227-36. PubMed ID: 8877536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic therapy in pneumonia. Cave resistance and pneumococcal loopholes].
    MMW Fortschr Med; 2007 Sep; 149(35-36):17. PubMed ID: 17944278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.